PathGen
Insights
Investing in health tech to tackle Indonesia’s greatest challenges
The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings requiring scalable solutions. Change doesn’t happen overnight, particularly for the healthcare sector, which consists of multiple intertwined industries with strict regulatory oversight. But because the industry is highly regulated,…
Press Release
PathGen raises funding from East Ventures and Royal Group Indonesia, making early disease detection and precision medicine more accessible
PathGen or PathGen Diagnostik Teknologi, an Indonesia-based healthcare biotechnology startup specializing in molecular testing solutions, announced today that it has raised funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm in Indonesia and Southeast Asia, and Royal Group Indonesia, a dynamic and…